Rubinstein-Taybi syndrome

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
Rubinstein-Taybi syndrome
Classification and external resources
ICD-10 Q87.2
ICD-9 759.89
OMIM 180849
DiseasesDB 29344
eMedicine derm/711  ped/2026
MeSH D012415

Rubinstein-Taybi syndrome (also known as Broad Thumb-Hallux syndrome) is a condition characterized by short stature, moderate to severe mental retardation, distinctive facial features, and broad thumbs and first toes. Other features of the disorder vary among affected individuals. People with this condition have an increased risk of developing noncancerous and cancerous tumors, leukemia, and lymphoma. This condition is inherited in an autosomal dominant pattern and is uncommon occurring in an estimated 1 in 125,000 births.

Contents

Features of Rubinstein-Taybi syndrome

An isolated case was described in 1957 by Michail and Matsoukas. In 1963 Rubinstein and Taybi described a larger series of cases. Typical features of the disorder include:

  • Broad thumbs and broad first toes
  • Mental disability
  • Small height, bone growth, small head
  • Cryptorchidism in males
  • Unusual faces - eyes, nose, palate

1 out of 300,000 children are born with RTS

Genetics

Rubinstein-Taybi syndrome is inherited in an autosomal dominant fashion.
Rubinstein-Taybi syndrome is inherited in an autosomal dominant fashion.
Mutations in the CREBBP gene cause Rubinstein-Taybi syndrome. The CREBBP gene makes a protein that helps control the activity of many other genes. The protein, called CREB binding protein, plays an important role in regulating cell growth and division and is essential for normal fetal development. If one copy of the CREBBP gene is deleted or mutated, cells make only half of the normal amount of CREB binding protein. A reduction in the amount of this protein disrupts normal development before and after birth, leading to the signs and symptoms of Rubinstein-Taybi syndrome.

Mutations in the EP300 gene are responsible for a small percentage of cases of Rubinstein-Taybi syndrome. These mutations result in the loss of one copy of the gene in each cell, which reduces the amount of p300 protein by half. Some mutations lead to the production of a very short, nonfunctional version of the p300 protein, while others prevent one copy of the gene from making any protein at all. Although researchers do not know how a reduction in the amount of p300 protein leads to the specific features of Rubinstein-Taybi syndrome, it is clear that the loss of one copy of the EP300 gene disrupts normal development.

References

  • Coupry I, Monnet L, Attia AA, Taine L, Lacombe D, Arveiler B (March 2004). "Analysis of CBP (CREBBP) gene deletions in Rubinstein-Taybi syndrome patients using real-time quantitative PCR". Human mutation 23 (3): 278-84. PMID 14974086.
  • Michail J, Matsoukas J, Theodorou S (April-June 1957). "[Arched, clubbed thumb in strong abduction-extension & other concomitant symptoms]". Revue de chirurgie orthopédique et réparatrice de l'appareil moteur 43 (2): 142-6. PMID 13466652.
  • Rubinstein JH, Taybi H (June 1963). "Broad thumbs and toes and facial abnormalities. A possible mental retardation syndrome". American journal of diseases of children 105: 588-608. PMID 13983033.

External links

de:Rubinstein-Taybi-Syndrom

fr:Syndrome de Rubinstein-Taybi

Personal tools
In other languages